Please assess the completion status of the following clinical trial:

Trial Title: Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes according to Canadian Diabetes Association definition~* Initiation of a SU at baseline~* A1c: 7.0% to 10.0%~* Willing and able to comply with study procedures~Exclusion Criteria:~* Current or previous usage (during the last 3 months) of insulin or repaglinide~* Use of medication known to interfere with glucose metabolism~* Insulin requiring patient: catabolic state and/or ketonuria~* Currently using CGMS or within the last 3 months~* Recent severe hypoglycemia (\<3 months)~* Pregnancy or breast-feeding~* Limited life expectancy, high level of functional dependency, extensive coronary disease at high risk of short term ischemic events or multiple major co-morbidities

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- T2DM at SU initiation (Type: None): T2DM newly prescribed a SU

Based on this trial design, predict the completion outcome and termination type (if applicable).